Connectivity maps for biosimilar drug discovery in venoms: The case of Gila Monster Venom and the anti-diabetes drug Byetta®
Keywords: Connectivity map; Drug discovery; Biosimilar drugs; Byetta®; Gila monster; Natural product libraries;